Back
Invesco S&P 500 GARP ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
52
SPGP
Invesco S&P 500 GARP ETF
Last Price:
106.81
Seasonality Move:
6.6%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
48.99
Seasonality Move:
65.72%
Buy
52
Invesco S&P 500 GARP ETF (SPGP)
is a Buy
Is Invesco S&P 500 GARP ETF a Buy, Sell or Hold?
- The current Invesco S&P 500 GARP ETF [SPGP] share price is $106.78. The Score for SPGP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SPGP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SPGP Stock Price Chart
What is Invesco S&P 500 GARP ETF's stock price today?
-
The Invesco S&P 500 GARP ETF share price today is $106.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPGP is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPGP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 59.85 | Buy |
| Chaikin Money Flow: | 148371 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.81 - 106.35) | Buy |
| Bollinger Bands (100): | (100.66 - 104.98) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | 317205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.81 - 49.49) | Buy |
| Bollinger Bands (100): | (34.86 - 47.92) | Buy |
SPGP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.29 | Buy |
| 20-day SMA: | 105.26 | Buy |
| 50-day SMA: | 102.9 | Buy |
| 200-day SMA: | 101.84 | Buy |
| 8-day EMA: | 106.3 | Buy |
| 20-day EMA: | 105.22 | Buy |
| 50-day EMA: | 103.8 | Buy |
| 200-day EMA: | 101.03 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.58 | Buy |
| 20-day SMA: | 46.67 | Buy |
| 50-day SMA: | 46.11 | Buy |
| 200-day SMA: | 38.62 | Buy |
| 8-day EMA: | 45.67 | Buy |
| 20-day EMA: | 45.85 | Buy |
| 50-day EMA: | 45.2 | Buy |
| 200-day EMA: | 38.5 | Buy |
Invesco S&P 500 GARP ETF Earnings Growth & SPGP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Invesco S&P 500 GARP ETF Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||